๐ŸŽ Black Friday: up to 50% off of annual plans
Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM ยท Real-Time Price ยท USD
1.050
-0.020 (-1.87%)
Nov 20, 2026, 4:00 PM EST - Market closed

Actinium Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
350.09-0.081.031.14
Revenue Growth
38788.89%---92.14%-9.96%-
Gross Profit
350.09-0.081.031.14
Operating Income
9.13-36.25-42.12-51.92-34.1-24.96
Net Income
10.6-33.89-38.24-48.82-33.02-24.77
Earnings Per Share
0.34-1.09-1.27-1.83-1.37-1.20
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
28.684872.976.68108.9177.83
Total Debt
1.161.691.572.112.580.31
Net Cash (Debt)
27.5246.371.3374.56106.3377.52
Net Cash Growth
-47.33%-35.09%-4.34%-29.87%37.16%23.39%
Net Cash Per Share
0.881.482.372.804.403.77

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.36-24.58-33.07-47.348.64-20.87
Capital Expenditures
-1.35-0.1-0.01-0.15-0.37-0.13
Free Cash Flow
-24.72-24.68-33.08-47.498.28-21
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%-100.00%100.00%100.00%
Operating Margin
26.07%-40274.44%--64098.76%-3311.07%-2182.17%
Pretax Margin
30.27%-37652.22%--60269.14%-3205.53%-2165.56%
Profit Margin
30.27%-37652.22%--60269.14%-3205.53%-2165.56%
FCF Margin
-70.61%-27426.67%--58627.16%803.69%-1835.58%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
----32.78-
PS Ratio
0.94471.41-1719.26263.49115.74